EMZ Partners teams-up with the management team of Ceva Santé Animale for the 5th time in 20 years .
With more than €1.2bn in revenues and a wide range of pharmaceutical products and vaccines for livestock (ruminants, swine, poultry) and companion animals, Ceva stands as the fifth largest player on the animal health market. EMZ has supported the company since its spin-off from Sanofi in 1999 and has notably structured the transaction which allowed the management team to gain control of the group in 2007.
